Biopsy | Group2 | Histology1 | L-score6 | pTpNM-stage (age, sex) | Relapse (years)3 | Tumour4 | Obs. (years) |
---|---|---|---|---|---|---|---|
181-I | Â | PTC | L0 | T2AN0M0, (37, M) | No | PT | 15 |
197-I | Â | PTC-FV, thyroiditis | L2 | T1BN0M0, (50, M) | No | PT | 14 |
198-IV | Â | PTC, some histologic dediff. | L0 | T2AN1BM0, (13, F) | No | PT | 14 |
219-II | PTC(diff) | PTC | L0 | T4AN0M0, (67, M) | No | PT | 6.0 (dead)5 |
222-IV | Â | PTC | L0 | T1BN1BM0, (37, F) | No | PT | 14 |
283-III | Â | PTC, thyroiditis | L1 | T2AN1BM0, (22, F) | No | PT | 12 |
300-V | Â | PTC, squamous cell metaplasia | L1 | T3AN0M0, (43, F) | No | PT | 11 |
317-IV | Â | PTC | L0 | T1N1AM0, (30, F) | LN (9.1) | LN (r) | 11 |
328-V | Â | PTC | L0 | T2BN1AM0, (27, F) | No | PT | 10 |
353-I | Â | PTC-FV | L0 | T3BN0M0, (70, M) | No | PT | 9.0 (dead) |
246-I | Â | PTC-R-M1 | L0 | T4AN1AM0, (79, F) | LN, Lung (4.7) | LN (r) | 9.0 (dead) |
247-IV | Â | PTC-PD-M1, thyroiditis | L2 | T4AN1AM1, (83, F) | Lung metastases at diagnosis | PT | 0.4 (dead) |
319-V | Â | PTC-PD | L1 | T4AN1AM0, (79, F) | Residual tumour in trachea | LN | 2.0 (dead) |
326-III | PTC(agg) | PTC-UD-M1 | L0 | T4AN1AM1, (72, M) | Lung metastases at diagnosis | PT | 0.1 (dead) |
345-III | Â | PTC-PD, squamous cell metaplasia | L1 | T1BN1BM0, (37, M) | LN | LN | 3.4 (dead) |
354-II | Â | PTC-PD | L0 | T4AN0M0, (80, F) | No | PT | 10 |
367-I | Â | PTC-PD-R-M1 | L0 | T4AN0M1, (81, F) | Lung metastases at diagnosis | LN | 1.3 (dead) |
379-I | Â | PTC-PD | L1 | T4BN1BM0, (74, F) | No | PT | 9.0 |